贵州三力: 贵州三力制药股份有限公司第四届董事会第十五次会议决议公告

Group 1 - The board of directors of Guizhou Sanli Pharmaceutical Co., Ltd. held its 15th meeting of the 4th session, which was conducted both in person and via communication voting [1][2] - All 9 directors attended the meeting, and the meeting was presided over by Chairman Zhang Hai, confirming compliance with legal and regulatory requirements [1] - The board approved the company's 2025 semi-annual report and summary, which will be disclosed on the Shanghai Stock Exchange website and other designated media [1][2] Group 2 - The voting results for the approved proposal were 9 votes in favor, with no abstentions, oppositions, or avoidance [2] - The proposal had previously been reviewed and approved by the company's audit committee [2]